Think it's great news, some of the weakest actors inside CUV are getting removed/removing themselves. Blijdorp and Keamy were absolute trainwrecks in annual meetings/investor meetings and would scare the hell out of any serious institutional investor. Additionally, Keamy did very little to keep the unbridled spending at CUV in check.
The decision to go into the highly competitive B2C skincare market, develop a complete new channel and skillset can prove to be extremely costly if not careful, a proper CFO needs to be on that monitoring investments and costs go hand in hand with (revenue) development. Let's hope the new CFO is a rockstar.
Think it's great news, some of the weakest actors inside CUV are...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.63 |
Change
0.120(0.89%) |
Mkt cap ! $682.3M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.77 | $13.43 | $581.2K | 42.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 248 | $13.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.64 | 1 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |